IMA

SetupConviction 47LongHealthcareScan · Mon, Jul 20, 2026

Ascending triangletriangle

IMA$5.99+11.25%

ResistanceSupportVol 14Insider buy

Vol MA14 234.04K

Apr 20May 6May 26Jun 11Jul 1Jul 20

Trade plan

LongReward : Risk0.86

Entry

6.22

Risk

Stop

5.60

-10.1% to stop

Reward

Target 1

6.77

+8.7% to target

Stretch

Target 2

7.31

+17.4% to T2

Risk : reward balance

Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

ImageneBio, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.imagenebio.com ↗

Price5.99

Change+11.25%

Gap+5.30%

Rel volume265.87×

Avg volume167.07K

Avg $ vol998.08K

SMA 205.91

SMA 505.75

SMA 2006.48

Price vs 50+4.07%

Price vs 200-7.70%

MA stackmixed

50/200 cross—

Supertrendup · 5.11

RSI (14)54

MACD hist-0.04

MACD crossbear · 2d

Stoch %K / %D68 / 26

ADX (14)16

+DI / −DI24 / 21

RSI divergence—

MACD divergence—

ATR %+5.71%

ADR %4.97%

52w high17.90

52w low4.55

From 52w high-66.56%

Above 52w low+31.54%

New 52w highNo

SqueezeOn · 13d

Bollinger width12.50%

%B0.60

Donchian pos67.86%

Donchian high6.30

Donchian low5.32

AVWAP (52w high)6.43

vs AVWAP high-6.95%

AVWAP (52w low)5.91

vs AVWAP low+1.24%

OBV trendUp

Chaikin MF (20)0.94

Today vs 20d265.87×

Avg vol (14d)234.04K

Avg vol (20d)167.07K

Avg $ vol (20d)998.08K

Market cap67.51M

RS 3m (vs SPY)-12.85%

RS 6m (vs SPY)-28.90%

RS line new highNo

Trend template—

Technical rank40.8

1 week-2.05%

1 month+5.18%

3 months+1.44%

6 months-9.04%

1 year—

YTD-11.46%

P/E-1.49

P/B0.55

P/S84.38

P/FCF-1.40

EPS-9.64

Div yield—

ROE-36.77%

ROA-33.18%

Debt/Eq0.00

Current18.39

EV/EBITDA0.18

Gross margin—

Net margin—

Rev growth-77.14%

EPS growth-24.01%

Price target13.00

Target upside117.21%

Analyst ratingBuy

Institutional54.30%

Ent. value-8.54M

Revenue800K

Net income-10.62M

Gross profit—

Free cash flow-48.26M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out11.28M

Employees17

ListedMon, Jul 28, 2025

Free float8.51M

Float %79.8%

Short interest404.37K

Days to cover31.5d

Short volume31.3%

Squeeze score50 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.95 vs −$0.70

Last surprise-35.7% miss

Setup gradeC

Conviction47 / 100

Pattern quality51%

Tech rank40.8 / 100

Group rank23 / 100

Status laneSetting up

Setup directionLong

Pattern familyTriangle

Resistance6.22

Support5.68

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 31 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Retesting breakout
Jun 18
1 scan
→
Setting up
Jun 26 – Jul 20
11 scans

Congress activity

Disclosed STOCK Act trades in IMA

All disclosures →

No recent disclosed trades by Congress in IMA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMA · 8 buys

Insider	Side	Shares	Value	Traded	Filed
Bonita David P Director · Stock Option (right to buy) · 2026-06-16	Grant	15.6K	—	2026-06-16	2026-06-18
SLATTERY JOSEPH P Director · Stock Option (right to buy) · 2026-06-16	Grant	15.6K	—	2026-06-16	2026-06-18
Stampacchia Otello Director · Stock Option (right to buy) · 2026-06-16	Grant	15.6K	—	2026-06-16	2026-06-18
Wang Jonathan Jian Director · Stock Option (right to buy) · 2026-06-16	Grant	15.6K	—	2026-06-16	2026-06-18
Bonita David P Director · Pre-Funded Warrants (right to buy) · 2026-04-14	Buy	384.69K	—	2026-04-14	2026-04-16
OrbiMed Capital GP VI LLC Director · Common Stock · 2026-04-14	Other	—	—	2026-04-14	2026-04-16
OrbiMed Capital GP VI LLC Director · Pre-Funded Warrants (right to buy) · 2026-04-14	Buy	384.69K	—	2026-04-14	2026-04-16
OrbiMed Capital GP VI LLC Director · Pre-Funded Warrants (right to buy) · 2026-04-14	Buy	336.6K	—	2026-04-14	2026-04-16
Bonita David P Director · Pre-Funded Warrants (right to buy) · 2026-04-14	Buy	336.6K	—	2026-04-14	2026-04-16
ORBIMED ADVISORS LLC Director · Common Stock · 2026-04-14	Other	—	—	2026-04-14	2026-04-16

SEC filings

EDGAR filings in IMA · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.